WHITNEY HALEY: Open Payments
NPI 1053713685 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 58 payments from 15 companies in 2025. Trend: 2023 $443 · 2024 $1,095 · 2025 $1,085
Food & beverage: $1,068Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $141 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| GENZYME CORPORATION | 5 | $125 |
| Verona Pharma, Inc. | 3 | $80 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Viatris Specialty LLC | 4 | $76 |
| Insmed, Inc. | 3 | $64 |
| United Therapeutics Corporation | 2 | $63 |
| Grifols USA, LLC | 2 | $39 |
Products named: DUPIXENT, FASENRA, TRELEGY ELLIPTA, Ohtuvayre, NUCALA, YUPELRI, JASCAYD, Tyvaso.
Industry payments across TN — which companies pay providers there.
